Mannitol Viaflo Baxter

Mannitol, the active ingredient in Mannitol Viaflo Baxter, is an osmotic diuretic presented as a sterile solution for injection for intravenous use. It reduces intracranial pressure, promotes diuresis in acute renal failure, and lowers intraocular pressure in patients requiring rapid fluid shifts.

GNH USA supplies Mannitol Viaflo Baxter as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides temperature‑controlled logistics for injectable products. Its global network ensures timely delivery to critical care settings.

Mannitol acts as an osmotic diuretic and is employed in conditions where rapid fluid shifts are needed. - Intracranial hypertension: reduces intracranial pressure by drawing water out of brain tissue. - Acute renal failure: promotes diuresis to aid renal clearance of waste products. - Elevated intraocular pressure: lowers eye pressure in glaucoma or ocular surgery settings.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate pain often transient. - Nausea or vomiting: gastrointestinal upset after infusion. - Electrolyte imbalance: hypokalemia or hypernatremia. - Transient hypotension: drop in blood pressure during rapid infusion. - Fluid overload: signs of edema in susceptible patients.

Serious or Rare Side Effects: - Acute renal failure exacerbation: worsening kidney function. - Pulmonary edema: fluid accumulation in lungs. - Severe electrolyte disturbances: dangerous shifts in sodium or potassium. - Anaphylactoid reaction: rash, bronchospasm, or shock. - Hemolysis: destruction of red blood cells. - Severe hypotension: profound drop in blood pressure requiring intervention.

Mannitol should be used with careful clinical monitoring. - Monitor electrolytes: check serum sodium and potassium levels regularly. - Assess renal function: evaluate creatinine and urine output before and during therapy. - Caution in heart failure: avoid volume overload in patients with compromised cardiac function. - Avoid rapid infusion: administer over the recommended time to reduce hypotension risk. - Adjust for dehydration: correct fluid deficits before initiating therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with several medications, requiring vigilance.

Major Interactions (Avoid): - Loop diuretics: may cause severe electrolyte imbalance. - ACE inhibitors: can enhance hypotensive effects. - Lithium: increased lithium serum concentrations. - Anticoagulants: heightened risk of bleeding due to volume shifts.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish diuretic efficacy. - Corticosteroids: can promote fluid retention. - Anticonvulsants: potential alteration of serum sodium affecting seizure control.